Foghorn Therapeutics (FHTX) Other Accumulated Expenses (2020 - 2025)
Historic Other Accumulated Expenses for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $396000.0.
- Foghorn Therapeutics' Other Accumulated Expenses rose 8591.55% to $396000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $396000.0, marking a year-over-year increase of 8591.55%. This contributed to the annual value of $1000.0 for FY2024, which is 9722.22% down from last year.
- Latest data reveals that Foghorn Therapeutics reported Other Accumulated Expenses of $396000.0 as of Q3 2025, which was up 8591.55% from $392000.0 recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Other Accumulated Expenses ranged from a high of $526000.0 in Q1 2025 and a low of $1000.0 during Q4 2024
- In the last 5 years, Foghorn Therapeutics' Other Accumulated Expenses had a median value of $255500.0 in 2022 and averaged $248562.5.
- In the last 5 years, Foghorn Therapeutics' Other Accumulated Expenses soared by 20000.0% in 2022 and then plummeted by 9722.22% in 2024.
- Foghorn Therapeutics' Other Accumulated Expenses (Quarter) stood at $392000.0 in 2021, then decreased by 18.88% to $318000.0 in 2022, then plummeted by 88.68% to $36000.0 in 2023, then crashed by 97.22% to $1000.0 in 2024, then surged by 39500.0% to $396000.0 in 2025.
- Its Other Accumulated Expenses was $396000.0 in Q3 2025, compared to $392000.0 in Q2 2025 and $526000.0 in Q1 2025.